Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
US Army
Argus Health
Express Scripts
Dow
Covington
US Department of Justice
Harvard Business School
Chinese Patent Office
Novartis

Generated: August 21, 2017

DrugPatentWatch Database Preview

Clonazepam - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clonazepam and what is the scope of clonazepam patent protection?

Clonazepam
is the generic ingredient in three branded drugs marketed by Roche, Teva, Sun Pharm Inds Inc, Sandoz, Mylan Pharms Inc, Accord Hlthcare, Mylan, Prinston Inc, Watson Labs, Apotex Inc, Actavis Elizabeth, Par Pharm, and Barr, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for clonazepam. Forty-nine suppliers are listed for this compound.

Summary for Generic Name: clonazepam

Tradenames:3
Patents:0
Applicants:13
NDAs:17
Drug Master File Entries: see list10
Suppliers / Packagers: see list49
Bulk Api Vendors: see list29
Clinical Trials: see list39
Patent Applications: see list5,348
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:clonazepam at DailyMed

Pharmacology for Ingredient: clonazepam

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
CLONAZEPAM
clonazepam
TABLET;ORAL074979-003Aug 29, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
CLONAZEPAM
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL077171-001Aug 3, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
CLONAZEPAM
clonazepam
TABLET;ORAL074925-001Sep 30, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Prinston Inc
CLONAZEPAM
clonazepam
TABLET;ORAL077856-003Jun 28, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
CLONAZEPAM
clonazepam
TABLET;ORAL074940-001Oct 30, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: clonazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche
KLONOPIN RAPIDLY DISINTEGRATING
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL020813-004Dec 23, 1997► Subscribe► Subscribe
Roche
KLONOPIN RAPIDLY DISINTEGRATING
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL020813-005Dec 23, 1997► Subscribe► Subscribe
Roche
KLONOPIN RAPIDLY DISINTEGRATING
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL020813-003Dec 23, 1997► Subscribe► Subscribe
Roche
KLONOPIN RAPIDLY DISINTEGRATING
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL020813-003Dec 23, 1997► Subscribe► Subscribe
Roche
KLONOPIN RAPIDLY DISINTEGRATING
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL020813-001Dec 23, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Federal Trade Commission
Daiichi Sankyo
Johnson and Johnson
Baxter
Mallinckrodt
Dow
Farmers Insurance
Queensland Health
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot